NFKBIB Antibody - N-terminal region

Artikelnummer: ASB-ARP34505_T100
Artikelname: NFKBIB Antibody - N-terminal region
Artikelnummer: ASB-ARP34505_T100
Hersteller Artikelnummer: ARP34505_T100
Alternativnummer: ASB-ARP34505_T100-25UL,ASB-ARP34505_T100-100UL
Hersteller: Aviva
Wirt: Rabbit
Kategorie: Proteine/Peptide
Applikation: WB
Spezies Reaktivität: Bovine, Canine, Equine, Guinea pig, Human, Mouse, Rabbit, Rat, Yeast
Immunogen: The immunogen is a synthetic peptide directed towards the N terminal region of human NFKBIB
Alternative Synonym: IKBB, TRIP9
Inhibition of NFkappa-B activity by the hepatitis C virus core protein might be related to its physical interaction with and interrupted nuclear localization of IKKbeta. Increased nuclear factor-kappaB (NF-kB) activity in the amnion during labor is associated with an increase in the expression of NF-kBp65 and of the NF-kB binding proteins IkBa, IkBb-1 and IkBb-2. IkappaBbeta may be a novel target for transcription factors of the HMG-box SRY/Sox family and imply a potential role for NF-kappaB/IkappaBbeta in spermatogenesis.
Klonalität: Polyclonal
Konzentration: 1.0 mg/ml
Molekulargewicht: 38kDa
NCBI: 4793
UniProt: Q15653
Formulierung: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
WB Suggested Anti-NFKBIB Antibody Titration: 1.25ug/ml
ELISA Titer: 1:62500
Positive Control: HepG2 cell lysate
Host: Mouse
Target Name: NFKBIB
Sample Tissue: Mouse Heart
Antibody Dilution: 1ug/ml
NFKBIB antibody - N-terminal region (ARP34505_T100) in Human HepG2 using Western Blot